spacer
home > epc > autumn 2002 > the future of wireless technologies in clinical drug trials
PUBLICATIONS
European Pharmaceutical Contractor

The Future of Wireless Technologies in Clinical Drug Trials

Two of the biggest challenges facing the pharmaceutical industry are the rising costs of clinical trials and the increasing time it takes for a drug to be delivered to market. On average, drug products now take 6.7 years to trial, an increase of over four years per trial since the 1960s, with the average trial costing between 1.5 million and 10 million.

Traditional drug trials generate huge amounts of administration and paperwork. According to Hybrid 4, a specialist in developing patient data collection software and integration, one small drug trial in the UK can generate up to 38 tons of paper. With 216 clinical drug trials taking place between 2000 and 2001, this represents, at a minimum, 8,000 tons of paper.

There is currently much discussion about the length of clinical trials and our society is all too aware that cures for debilitating diseases take years, often decades, to be developed or discovered. Changes and advances in technology, and particularly in wireless technology, offer a safe and effective method of revolutionising the industry by helping to speed up the trial process.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Richard Hanscott, Vice-President of Business Solutions at Orange UK

Richard Hanscott is Vice-President of Business Solutions at Orange UK. He is responsible for all existing operations and future strategy for business markets in the UK.

Prior to joining Orange, Richard worked in the information technology sector for over 14 years and came to Orange from Hewlett Packard where he held a number of senior positions. Richard holds a B Tech (Hons) in Mechanical Engineering from Loughborough University.

spacer
Richard Hanscott
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

White Papers

The EC Definition of a Nanomaterial - Potential Measurement Methodologies

NanoSight

In October 2011 the European Commission published a definition of Nanomaterials. This move followed more than six years of scientific consideration of the potential toxicological and environmental challenges posed by engineered nanomaterials.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement